Endothelin-1, which is a potent vasoconstrictor, is increased with VEGF inhibition, and endothelin antagonism appears to limit the development of hypertension, although the mechanism by which VEGF inhibitors activate endothelin-1 has not been clearly established52,53. The gene discussed is VEGFA; the disease is hypertensive disorder.